The Patent Finder

Terms ending in 2038

Ablynx N.V.

Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,630,617Serum Albumin Binders
In force
 · High confidence
SanofiIn forceHigh confidence
US 11,046,767T Cell Recruiting Polypeptides Based on CD3 Reactivity
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 11,414,481Serum Albumin Binders
In force
 · High confidence
SanofiIn forceHigh confidence
US 11,414,480Improved Serum Albumin Binding Immunoglobulin Single Variable Domains
In force
 · High confidence
SanofiIn forceHigh confidence
US 11,261,260Adamts Binding Immunoglobulins
In force
 · High confidence
Ablynx N.V. and SanofiIn forceHigh confidence
US 11,603,401Aggrecan Binding Immunoglobulins
In force
 · High confidence
Merck Patent GmbHIn forceHigh confidence
US 12,129,308MMP13 Binding Immunoglobulins
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 11,840,569T Cell Recruiting Polypeptides Capable of Binding CD123 and TCR Alpha/Beta
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
US 11,952,418Biparatopic Polypeptides Antagonizing WNT Signaling in Tumor Cells
In force
 · High confidence
Boehringer Ingelheim International GmbHIn forceHigh confidence
US 11,248,055Polypeptides Inhibiting CD40L
In force
 · High confidence
Ablynx N.V.In forceHigh confidence
2 more term ends in 2038 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
7 of these are in force and held by Ablynx N.V..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited